Tocainide
Back to searchMolecule Structure
Scientific Name
Tocainide
Description of the Drug
Tocainide is an orally active class 1b antiarrhythmic agent that interferes with cardiac sodium channels and typically used to treat ventricular arrhythmias.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01056
http://www.drugbank.ca/drugs/DB01056
Brand Name(s)
Not Available
Company Owner(s)
Astrazeneca Pharmaceuticals Lp
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Sodium channel alpha subunit | PROTEIN FAMILY | BLOCKER | CHEMBL2331043 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL15761 |
PharmGKB | PA451706 |
Human Metabolome Database | HMDB0015189 |
DrugBank | DB01056 |
PubChem: Thomson Pharma | 14797358 |
PubChem | 38945 |
Mcule | MCULE-9641637435 |
LINCS | LSM-1909 |
Nikkaji | J16.873D |
EPA CompTox Dashboard | DTXSID9040766 |
DrugCentral | 2686 |
ChemicalBook | CB8210193 |
Guide to Pharmacology | 7309 |
rxnorm | TOCAINIDE |
KEGG Ligand | C07142 |
ChEBI | 9611 |